Firms
Gates Frontier
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
GVLifeMine$188M · 2026-08-06
Cerevance$20M · 2026-05-12
Cerevance$47M · 2024-04-25
Nimbus Therapeutics$210M · 2023-09-06
Cerevance$51M · 2023-02-13
Khosla VenturesGlydways, Inc.$250M · 2026-04-14
Mainspring Energy$258M · 2025-04-14
Mainspring$258M · 2025-04-14
Glydways, Inc.$56M · 2023-10-06
Synchron$75M · 2022-12-15
Lightstone Ventures
Cerevance$20M · 2026-05-12
Cerevance$47M · 2024-04-25
Nimbus Therapeutics$210M · 2023-09-06
Cerevance$51M · 2023-02-13
DCVC
Mainspring Energy$258M · 2025-04-14
Mainspring$258M · 2025-04-14
General Catalyst
Mainspring Energy$258M · 2025-04-14
Mainspring$258M · 2025-04-14
Lightrock
Mainspring Energy$258M · 2025-04-14
Mainspring$258M · 2025-04-14
Marunouchi Innovation Partners
Mainspring Energy$258M · 2025-04-14
Mainspring$258M · 2025-04-14
RA Capital Management
LifeMine$188M · 2026-08-06
Nimbus Therapeutics$210M · 2023-09-06
Temasek Holdings (Private) Limited
Mainspring Energy$258M · 2025-04-14
Mainspring$258M · 2025-04-14
Agent Capital
Cerevance$47M · 2024-04-25
Alumni Ventures
Synchron$75M · 2022-12-15
Atlas Venture
Nimbus Therapeutics$210M · 2023-09-06
Bain Capital Life Sciences
Nimbus Therapeutics$210M · 2023-09-06
Bioluminescence Ventures
Cerevance$47M · 2024-04-25
BVF Partners L.P.
Nimbus Therapeutics$210M · 2023-09-06
Dolby Family Ventures
Cerevance$51M · 2023-02-13
Forepont Capital Partners
Synchron$75M · 2022-12-15
Foresite Capital
Cerevance$51M · 2023-02-13
ID8 Investments
Synchron$75M · 2022-12-15
LifeRock Ventures
Cerevance$47M · 2024-04-25
METIS Innovative
Synchron$75M · 2022-12-15
Moore Strategic Ventures
Synchron$75M · 2022-12-15
MRL Ventures Fund
LifeMine$188M · 2026-08-06
Neuro Technology Investors
Synchron$75M · 2022-12-15
Pfizer Ventures
Nimbus Therapeutics$210M · 2023-09-06
Reliance Digital Health
Synchron$75M · 2022-12-15
Science
Glydways, Inc.$56M · 2023-10-06
Shanda Group
Synchron$75M · 2022-12-15
SR One
Nimbus Therapeutics$210M · 2023-09-06
SV Health Investors
Nimbus Therapeutics$210M · 2023-09-06
Takeda Ventures, Inc.
Cerevance$51M · 2023-02-13
University of Melbourne
Synchron$75M · 2022-12-15



